Encompass Health Co. (NYSE:EHC) Shares Sold by Sit Investment Associates Inc.

Sit Investment Associates Inc. decreased its position in shares of Encompass Health Co. (NYSE:EHC) by 0.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 68,475 shares of the company’s stock after selling 150 shares during the quarter. Sit Investment Associates Inc. owned 0.07% of Encompass Health worth $6,324,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also modified their holdings of the company. MassMutual Private Wealth & Trust FSB boosted its position in Encompass Health by 87.8% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company’s stock worth $27,000 after purchasing an additional 137 shares in the last quarter. CBIZ Investment Advisory Services LLC raised its stake in shares of Encompass Health by 38.7% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company’s stock worth $42,000 after buying an additional 127 shares during the last quarter. Tompkins Financial Corp acquired a new stake in Encompass Health in the 4th quarter valued at about $46,000. V Square Quantitative Management LLC increased its holdings in Encompass Health by 43.8% during the 4th quarter. V Square Quantitative Management LLC now owns 581 shares of the company’s stock valued at $54,000 after acquiring an additional 177 shares in the last quarter. Finally, Signaturefd LLC increased its holdings in Encompass Health by 21.6% during the 4th quarter. Signaturefd LLC now owns 704 shares of the company’s stock valued at $65,000 after acquiring an additional 125 shares in the last quarter. Institutional investors and hedge funds own 97.25% of the company’s stock.

Analysts Set New Price Targets

Several analysts have recently commented on the stock. William Blair reiterated an “outperform” rating on shares of Encompass Health in a research report on Friday, February 7th. Barclays increased their target price on Encompass Health from $116.00 to $118.00 and gave the company an “overweight” rating in a report on Friday, February 7th. StockNews.com cut Encompass Health from a “buy” rating to a “hold” rating in a report on Thursday. Royal Bank of Canada reiterated an “outperform” rating and set a $110.00 price objective on shares of Encompass Health in a research report on Tuesday, February 11th. Finally, KeyCorp upped their target price on shares of Encompass Health from $117.00 to $120.00 and gave the company an “overweight” rating in a report on Monday, February 10th. One research analyst has rated the stock with a hold rating, nine have assigned a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat.com, Encompass Health has a consensus rating of “Buy” and an average target price of $107.67.

Insider Transactions at Encompass Health

In other Encompass Health news, CAO Andrew L. Price sold 5,042 shares of the firm’s stock in a transaction dated Thursday, February 13th. The stock was sold at an average price of $98.29, for a total value of $495,578.18. Following the transaction, the chief accounting officer now directly owns 69,164 shares of the company’s stock, valued at $6,798,129.56. This trade represents a 6.79 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Company insiders own 2.10% of the company’s stock.

Encompass Health Trading Down 3.7 %

Shares of EHC stock opened at $98.14 on Friday. Encompass Health Co. has a 1-year low of $78.53 and a 1-year high of $104.55. The firm’s 50-day simple moving average is $99.25 and its 200-day simple moving average is $97.71. The firm has a market cap of $9.88 billion, a P/E ratio of 22.00, a PEG ratio of 2.31 and a beta of 0.87. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.05 and a quick ratio of 1.04.

Encompass Health (NYSE:EHC) last announced its quarterly earnings data on Thursday, February 6th. The company reported $1.17 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. As a group, equities analysts forecast that Encompass Health Co. will post 4.8 EPS for the current year.

Encompass Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be paid a $0.17 dividend. This represents a $0.68 annualized dividend and a dividend yield of 0.69%. The ex-dividend date of this dividend is Tuesday, April 1st. Encompass Health’s dividend payout ratio is currently 15.25%.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.